Briefium Intelligence Dispatch
Can HBAR Reach $0.25 in 2026 as AlphaPepe's Stage 15 Sell-Out Keeps Stage 16 Demand Hot?
May 11, 2026 at 11:42 AM UTC•17 hours ago
The piece centers Hedera’s price outlook, weighing a potential 2026 target of $0.25 against AlphaPepe’s Stage 16 presale momentum. It highlights Hedera’s enterprise adoption and tokenization as longer-term catalysts, while noting AlphaPepe’s fast retail-driven setup, Stage 16 demand, AlphaSwap operations, a 10/10 audit, and near $1.2M funding ahead of Q2 listing. Key takeaway: Hedera needs stronger enterprise momentum for the price target, whereas AlphaPepe drives near-term trading interest.
External Source
Read the Full Report
This executive summary captures the key intelligence. For the complete dataset, charts, and expert commentary, access the original source.